Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,545
datasets available to search
ShareScore release 0.9.0
Dataset results
1,545 results for “type 2 diabetes mellitus”
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
ClinicalTrials.gov study NCT03199053. IPD Sharing: YES. Countries: 23. Publications: 1.
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT01152385. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
ClinicalTrials.gov study NCT00734474. IPD Sharing: Not stated. Countries: 13. Publications: 7.
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02121483. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy
ClinicalTrials.gov study NCT07278115. IPD Sharing: YES. Countries: 1. Publications: 2.
Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03231709. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00856284. IPD Sharing: Not stated. Countries: 32. Publications: 1.
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY
ClinicalTrials.gov study NCT04617275. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02863419. IPD Sharing: Not stated. Countries: 13. Publications: 7.
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
ClinicalTrials.gov study NCT01131676. IPD Sharing: Not stated. Countries: 42. Publications: 39.
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00943917. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive
ClinicalTrials.gov study NCT01939496. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study for Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00871572. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inad
ClinicalTrials.gov study NCT02911948. IPD Sharing: Not stated. Countries: 1. Publications: 3.
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00135330. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00885378. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
ClinicalTrials.gov study NCT02332824. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT03430856. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
ClinicalTrials.gov study NCT03353350. IPD Sharing: NO. Countries: 5. Publications: 1.
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
ClinicalTrials.gov study NCT01075282. IPD Sharing: Not stated. Countries: 20. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.